6- Dermatology (Emergency:Anaphylaxis, Erythema nodosum, Erythema multiforme, Necrotising fascitis, Steven Johnson Syndrome)) Flashcards

1
Q

urticaria background

A
  • Also known as hives
  • A superficial swelling of the skin (epidermis and mucous membranes) that results in a red (initially with a pale centre), raised, and intensely itchy rash.
  • Can be localised or widespread
  • May be associated with angioedema and flushing
  • Classification
    o Acute
    o Chronic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathophysiology of urticaria

A
  • Causes by release of histamine and other pro-inflammatory chemicals (leukotrienes, prostaglandins) by mast cells
  • Acute: allergic reaction
  • Chronic: autoimmune
    o Autoantibodies target mast cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

acute causes of urticaria

A

(mast cell release of histamine)
o Allergies to food
o Contact with chemicals, latex, nettles
o Medication
o Viral infections
o Insect bites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

chronic causes of urticaria

A
  • Chronic idiopathic urticaria: describes recurrent episodes without a clear cause
  • Chronic inducible urticaria: induced by certain triggers:
    o Sunlight
    o Temp change
    o Exercise
    o Strong emotions
  • Autoimmune urticaria
    o E.g. SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

presentation of urticaria

A
  • Pruritus
  • Vascular permeability
  • Oedema
  • Rash: erythematous swelling of various shapes and sizes, classically have central pallor with erythematous flare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

urticaria management

A

Management
- Antihistamines e.g. Fexofenadine (chronic), cetrixzine (acute)
- Oral steroids (Prednisone)may be considered for short course for severe flare
- Third line:
o Anti-leukotrienes e.g. Montelukast
o Omalizumab- target IgE
o Cyclosporin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

angio-oedema vs urticaria

A
  • Angio-oedema is a deeper form of urticaria with transient swellings of deeper dermal, subcutaneous, and submucosal tissues, often affecting the face (lips, tongue, and eyelids), genitalia, hands, or feet. For more information, see the CKS topic on Angio-oedema and anaphylaxis
  • Urticaria and angio-oedema can co-exist (in about 40% of cases), but either can occur separately
  • Consider vasculitis urticaria – if lesion remain for longer 24hs and are painful, non blanching and palpable (esp in conjunction with fever, malaise and arthralgia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Patient with anaphylaxis

A

Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction which is likely when both of the following criteria are met:

  • Sudden onset and rapid progression of symptoms.
  • Life-threatening airway and/or breathing and/or circulation problems.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Classic signs of anaphylaxis

A

flushing, urticaria, angio-oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

anaphylaxis aetiology

A
  • Allergen reacts with specific IgE antibodies on mast cells and basophils (type 1 hypersensitivity reaction), triggering the rapid release of stored histamine and rapid synthesis of newly formed mediators, causing:
    o Capillary leakage
    o Mucosal oedema
    o Shock
    o Asphyxia
  • Usually occur over a few minutes or occasionally biphasic (may be delayed. By a few hours)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

presentation of anaphylaxis

A
  • Usually history of previous sensitivity to an allergen or recent exposure to a new drug

Skin symptoms
- Itching
- Urticaria
- Erythema
- Rhinitis
- Conjuncitivits
- Angio-oedema

Airway involvement
- Early: Itching of the palate or external auditory meatus
- Dyspnoea
- Laryngeal oedema (strodros)
- Wheezing (bronchospasm)

General symptoms
- Palpitations
- Tachycardia
- Nausea
- Vomiting
- Abdominal pain
- Faint
- Sense of impending doom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Common triggers of anaphylaxis

A
  • Peanuts
  • Eggs
  • Milk
  • Venom e.g. bee sting
  • Drugs
    o Antibiotics
    o Opioids
    o NSAIDs
    o Contrast
    o Anaesthetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Emergency treatment

of anaphylaxis

A

Rapid assessment: A-E

  • Give high flow oxygen (15l through a non rebreathe mask)
  • Lay patient flat and raise legs
  • Adrenaline IM in anterolateral aspect of the middle third of thigh
    o Adult 500mg IM
    o Child IM
     >12 500mg
     6-12- 300 mg
     <6 years 150mg
    o Should be repeated after 5 mins if no clinical improvement
  • IV fluid challenge- warmed crystalloid solution e.g. Hartmanns or saline to raise BP
  • Chlorphenamine
  • Hydrocortisone
  • Continuing resp deterioration -> bronchodilators e.g. salbutamol
  • Monitor
    o Pulse oximetry
    o ECG
    o BP

Further investigation
- Serum mast-cell tryptase -> clarify diagnosis -> demonstrates mast-cell degranulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Erythema nodosum
Background

A
  • A type of panniculitis, an inflammatory disorder affecting subcutaneous fat
  • Disorder where red lumps appear across the patients shins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

erythema nodosum Pathophysiology

A
  • Inflammation of subcut fat in the shins -> panniculitis
  • Hypersensitivity reaction of unknown cause in most patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

erythema nodosum is more common in

A

women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

triggers of erythema nodosum

A

Infection
- Streptococcal (group A beta-haemolytic)
- TB
- Gastroenteritis

Drug
- Amoxicillin
- Oral contraceptive

Chronic disease
- Sarcoidosis
- Inflammatory condition
- IBD
- Malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Presentation of erythema nodosum

A
  • Bilateral tender erythematous nodules on the anterior shins (less commonly, thighs and forearms (rarely on face)
  • 3-20cm
  • Lesions do not ulcerate and resolve without scarring
  • Accompanied by fever and joint pain – swollen ankle most common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

investigations for erythema nodosum

A
  • Inflammatory markers (CRP and ESR)
  • Throat swab for streptococcal infection
  • Chest xray can help identify mycoplasma, tuberculosis, sarcoidosis and lymphoma
  • Stool microscopy and culture for campylobacter and salmonella
  • Faecal calprotectin for inflammatory bowel disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

management of erythema nodosum

A
  • Treatment of underlying condition e.g. Crohn’s, sarcoidosis, tuberculosis, throat infection
  • Anti-inflammatory drugs e.g. ibuprofen and hydrocortisone
  • They spontaneously resolve within 6-8 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Erythema multiforme (major and minor)
Background

A
  • Hypersensitivity reaction usually triggered by infections, most commonly herpes simplex virus (HSV)
  • Divided into major and minor forms
22
Q

rf for erythema multiforme

A
  • Usually young adults
  • Genetic tendency
23
Q

triggers for erythema multiforme

A

Infections
- Herpes simplex most common
- Mycoplasma pneumonia
- Parapoxviral
- Herpes varicella-zoster
- Adenovirus
- Hepatitis virus
- Dermatophyte fungal infections

Drugs
Barbiturates, NSAIDS, penicillin

24
Q

presentation of erythema multiforme

A
  • Eruption characterised by target lesion (few to hundreds within 24 hours)
  • Itchy
  • First seen on the back of hands/ top of feet and then spread down limb towards trunk
  • Mucous membranes may be involved- stomatitis
  • May have fever or chills and arthralgia -> flu symptoms
25
Q

investigations for erythema multiforme

A

Investigations
- If no clear underlying cause: chest X-ray looking for mycoplasma pneumonia

26
Q

management of erythema multiforme

A
  • Treatment of underlying condition
  • Acute and self limiting, usually resolving without complication
  • Skin biopsy may need to done to exclude other conditions
  • if severe
    o Itch- antihistamine/corticosteroids topical
    o IV fluids
    o Analgesia
    o Systemic steroids (controversial)
    o Abx if infection present
  • Eye involvement should be treated by ophthalmologist
  • Recurrent erythema multiforme usually treated with oral acyclovir for 6 months
27
Q

Scalded skin syndrome
Background

A
  • Commonly seen in infancy and childhood <5
  • Due to a type of Staph aureus that produces epidermolytic toxins , which are protease enzymes
  • These enzymes break down skin
28
Q

cause of scalded skin syndrome

A

Risk factors/causes
- Due to circulating epidermolytic toxin from phage group, II, benzylpenicillin resistant (coagulase positive) staphylococcic

29
Q

presentation of scalded skin syndrome

A
  • Develops within a few hours to a few days, and may be worse over
    the face, neck, axillae or groins
  • A scald-like skin appearance is followed by large flaccid bulla
  • Perioral crusting is typical
  • There is intraepidermal blistering in this condition
  • Lesions are very painful
  • Sometimes the eruption is more localised
  • Recovery is usually within 5-7 days
  • Systemic symptoms
30
Q

sign associated with scalded skin syndrome

A

Nikolsky sign is where very gentle rubbing of the skin causes it to peel away. This is positive in SSSS.

31
Q

management of scalded skin syndrome

A

Management
- Antibiotics - IV penicillinase-resistant penicillin e.g. erythromycin
- Analgesia
- IV Fluid

Prognosis/ complications
- If treated quickly no scaring
- Can causes sepsis

32
Q

Necrotizing fasciitis
Background

A
  • Necrotising fasciitis is a very serious bacterial infection of the soft tissue and fascia.
  • The bacteria multiply and release toxins and enzymes that result in thrombosis in the blood vessels
  • The result is the destruction of the soft tissues and fascia.
33
Q

main types of nec fas

A
34
Q

causes of nec fas

A
  • Most cases are of streptococcal necrotising fasciitis in young individuals
    o Group A haemolytic streptococcus
  • Opening in the skin e.g.
  • Mandibular fracture and dental infection
  • Direct contact with someone else with it
35
Q

Risk factors for nec fas

A

o Recent surgery
o NSAIDS
o Older
o DM
o Immunosuppression
o Obesity
o Drug abuse

36
Q

eary symptoms of nec fas

A
  • Small but painful cut or scratch on the skin that cause intense pain that’s out of proportion to any damage to the skin
  • High temperature (fever) and other flu-like symptoms
37
Q

nec fas after a few hours to days

A
  • Swelling and redness in the painful area – the swelling will usually feel firm to the touch
  • Diarrhoea and vomiting
  • Dark blotches on the skin that turn into fluid-filled blisters
  • Subcutaenous emohysema – crepitus
38
Q

investigations for necrotising fascitis

A
  • Plain X-ray or CT scan may show soft tissue gas
    o Absence should not exclude diagnosis
39
Q

management of nec fas

A
  • URGENT surgical debridement
  • IV Antibiotics
    o Vancomycin IV plus clindamycin
  • Supportive treatment e.g. IV fluids
40
Q

progonis of nec fas

A

76% mortality

41
Q

Pathophysiology of NF

A

The infection starts in the superficial fascia. Enzymes and proteins released by the responsible micro-organisms cause necrosis of fascial layers. Horizontal spread of infection may not be clinically apparent on the skin surface and hence diagnosis may be delayed. The infection then spreads vertically up into the skin and down into deeper structures. Thrombosis occludes the arteries and veins leading to ischaemia and necrosis of the tissues.

42
Q

Steven Johnson syndrome and Toxic Epidermal Necrolysis
Background

A
  • Immune-complex-mediated hypersensitivity disorder (Type 4).
  • SJS and TEN are a spectrum of the same pathology
  • Ranges from mild skin and mucous membrane lesions to a severe, sometimes fatal systemic illness
  • Pathology: due to disproportional immune response which causes epidermal necrosis, resulting in blistering and shedding of the top layer of kin
43
Q

Toxic epidermal necrolysis (ten) vs steven johnson (Sjs)

A

sjs/ten overlap and TEN form a spectrum of severe cutaneous adverse reactions (scar) that can be differentiated by the degree of skin and mucous membrane involvement.
- SJS <10% of the body
- TEN >10% of the body

44
Q

Risk factors for TEN/SJS

A
  • HLA genetic type at higher risk
  • More common in those with HIV and in females, most patient 10-30
45
Q

causes of TEN/SJS

A

Drugs
- Allopurinol
- Anti-epileptics
o Carbamazepine
o Phenytoin, lamotrigine
- Anti biotics
o Trimethoprim Abacavir
- NSAIDs

Infection
- Viral: HSV, Epstein- barr virus, enteroviruses, HIV
- Bacteria: Group A beta-haemolytic streptococcus, diphtheria, brucellosis, mycobacteria, Mycoplasma pneumoniae
- Protozoal: malaria and trichomoniasis

46
Q

general presentation of TEN/SJS

A

Presentation
- Nonspecific URTI, fever, sore throat, chills, headache, muscle ache, V and D
- Mucocutaneous lesions develop suddenly and clusters of outbreaks last from 2-4 weeks
- Severe mucosal ulceration
- Pt with genitourinary involvement complain of dysuria

47
Q

skin presentation of TEN/SJS

A
  • Lesions occur mainly on palms, soles, dorsum of hands, extensor surfaces, trunk
  • Macules -> papules -> vesicles -> blue -> urticarial plaques
  • Centre of the lesion may. Be vesicular, purpuric or necrotic
  • Target
  • Lesions become bullous and rupture
    - Not pruritic
  • Nikolsky sign positive
  • Corneal ulceration
48
Q

signs of TEN/SJS

A

Tachycardia, hypotension, fever, seizure, coma

49
Q

investigations for TEN/SJS

A
  • Skin biopsy will demonstrate bullae are subepidermal
50
Q

Management of TEN/SJS

A
  • Remove causative drug
  • Intensive care may be required
  • Supportive e.g. IV fluid, pain control, lesions treated as burns, nutrition
  • Topical anaesthetics, eye care
  • Treat secondary infection
  • Immunomodulation e.g. corticosteroids, DMARDS e.g. ciclosporin, anti-TNF monoclonal
51
Q

Complications of TEN/SJS

A
52
Q

Complications of TEN/SJS

A
  • Secondary infection: The breaks in the skin can lead to secondary bacterial infection, cellulitis and sepsis.
  • Permanent skin damage: Skin involvement can lead to scarring and damage to skin, hair, nails, lungs and genitals.
  • Visual complications: Depending on the severity, eye involvement can range from sore eyes to severe scarring and blindness.